# Replacing Mechanical Motion in X-ray Imaging: Varex Multi-Beam X-ray (MBX) Technology - Varex Imaging
Canonical URL: https://biopharmsignal.com/news/VREX/replacing-mechanical-motion-in-x-ray-imaging-varex-multi-beam-x-ray-mbx-technolo-15a26bbf
Ticker: VREX
Company: Varex Imaging
Source: Varex Imaging
Published: 2026-07-07 17:49 EST
Original Source URL: https://www.vareximaging.com/news/
## Summary

Varex Imaging’s Multi-Beam X-ray (MBX) technology introduces a fundamentally new approach to X-ray generation. By replacing mechanical motion with electronically controlled X-ray beams, MBX enables faster, more robust, and more flexible imaging system architectures. This innovation unlocks new 3D imaging geometries, improves image quality, and creates a differentiated platform for OEMs seeking next-generation performance. Read […]

## Article Body
June 30, 2026

Varex Imaging’s Multi-Beam X-ray (MBX) technology introduces a fundamentally new approach to X-ray generation. By replacing mechanical motion with electronically controlled X-ray beams, MBX enables faster, more robust, and more flexible imaging system architectures. This innovation unlocks new 3D imaging geometries, improves image quality, and creates a differentiated platform for OEMs seeking next-generation performance. Read […]

Varex Imaging’s Multi-Beam X-ray (MBX) technology introduces a fundamentally new approach to X-ray generation. By replacing mechanical motion with electronically controlled X-ray beams, MBX enables faster, more robust, and more flexible imaging system architectures. This innovation unlocks new 3D imaging geometries, improves image quality, and creates a differentiated platform for OEMs seeking next-generation performance.

Read the full white paper here:

06

Articles
## Recent Company News
- 2026-07-09 15:15 EST — [VAREX TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE - Varex Imaging](https://biopharmsignal.com/news/VREX/varex-to-present-at-the-jefferies-global-healthcare-conference-varex-imaging-7485a79a) — Source: Varex Imaging
- 2026-07-08 16:03 EST — [The GigaCT: Advancing Photon-Counting CT for Next-Generation Spectral Imaging - Varex Imaging](https://biopharmsignal.com/news/VREX/the-gigact-advancing-photon-counting-ct-for-next-generation-spectral-imaging-var-753f47a9) — Source: Varex Imaging
- 2026-07-07 17:53 EST — [White Paper: Pyxis™ Photon-Counting CT Detection Platform – Simplifying the Integration of Photon-Counting Computed Tomography - Varex Imaging](https://biopharmsignal.com/news/VREX/white-paper-pyxis-photon-counting-ct-detection-platform-simplifying-the-integrat-9b2cc7b7) — Source: Varex Imaging
- 2026-07-07 17:49 EST — [Replacing Mechanical Motion in X-ray Imaging: Varex Multi-Beam X-ray (MBX) Technology - Varex Imaging](https://biopharmsignal.com/news/VREX/replacing-mechanical-motion-in-x-ray-imaging-varex-multi-beam-x-ray-mbx-technolo-15a26bbf) — Source: Varex Imaging
- 2026-06-29 18:05 EST — [Tackling CT artifacts in multi-material parts: TrueSpectrum™ at ECNDT 2026 - Varex Imaging](https://biopharmsignal.com/news/VREX/tackling-ct-artifacts-in-multi-material-parts-truespectrum-at-ecndt-2026-varex-i-b14701de) — Source: Varex Imaging
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)